Alexandria Venture Investments was among the participants in the cancer radiotherapy startup's second round in under two months.

Lilly Asia Ventures co-led the first round for the CNS disease drug developer, which is headed by one of its former venture partners.

Stanford University supplied capital to help its AI cell analysis spinout Deepcell close its second funding round.

Science Creates will combine a $20m fund with wet-lab incubation to foster the west of England deep tech ecosystem in partnership with University of Bristol.

Heritage Group has exited Workpath, a developer of in-home care management software, through an acquisition by Ro.

Amgen is a shareholder of Vigil Neuroscience, which is developing microglia-based treatments for neurodegenerative diseases.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Kaiser Foundation Hospitals helped anti-ageing therapy developer BioAge Labs increase its overall funding to $137m.

Lilly Asia Ventures contributed to a round for the diabetes device developer that was co-led by Tencent, Beijing Taikang Investment Management and IDG Capital.

The Virginia Tech-allied brain injury diagnosis software company attracted Virginia Tech Carilion Innovation Fund in what appears to be its first round of funding.